Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Other Non-Current Assets (2020 - 2023)

Historic Other Non-Current Assets for Candel Therapeutics (CADL) over the last 4 years, with Q3 2023 value amounting to $300000.0.

  • Candel Therapeutics' Other Non-Current Assets rose 1278.2% to $300000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $300000.0, marking a year-over-year increase of 1278.2%. This contributed to the annual value of $300000.0 for FY2022, which is 2924.53% down from last year.
  • Candel Therapeutics' Other Non-Current Assets amounted to $300000.0 in Q3 2023, which was up 1278.2% from $300000.0 recorded in Q2 2023.
  • Candel Therapeutics' 5-year Other Non-Current Assets high stood at $1.7 million for Q2 2021, and its period low was $266000.0 during Q2 2022.
  • In the last 4 years, Candel Therapeutics' Other Non-Current Assets had a median value of $300000.0 in 2022 and averaged $461545.5.
  • In the last 5 years, Candel Therapeutics' Other Non-Current Assets skyrocketed by 2149.0% in 2021 and then tumbled by 8446.26% in 2022.
  • Candel Therapeutics' Other Non-Current Assets (Quarter) stood at $349000.0 in 2020, then rose by 21.49% to $424000.0 in 2021, then fell by 29.25% to $300000.0 in 2022, then changed by 0.0% to $300000.0 in 2023.
  • Its Other Non-Current Assets stands at $300000.0 for Q3 2023, versus $300000.0 for Q2 2023 and $300000.0 for Q1 2023.